Selecting machine-learning scoring functions for structure-based virtual screening

PJ Ballester - Drug discovery today: technologies, 2019 - Elsevier
Interest in docking technologies has grown parallel to the ever increasing number and
diversity of 3D models for macromolecular therapeutic targets. Structure-Based Virtual …

Shape-based generative modeling for de novo drug design

M Skalic, J Jiménez, D Sabbadin… - Journal of chemical …, 2019 - ACS Publications
In this work, we propose a machine learning approach to generate novel molecules starting
from a seed compound, its three-dimensional (3D) shape, and its pharmacophoric features …

Computational opportunities and challenges in finding cyclic peptide modulators of protein–protein interactions

F Duffy, N Maheshwari, NV Buchete, D Shields - Cyclic Peptide Design, 2019 - Springer
Peptide cyclization can improve stability, conformational constraint, and compactness.
However, apart from beta-turn structures, which are well incorporated into cyclic peptides …

[图书][B] Leveraging binding-site structure for drug discovery with point-cloud methods

V Mallet - 2019 - search.proquest.com
The drug discovery process starts with in-silico exploration of chemicals and is now using
more and more machine learning to leverage the data held by pharmaceuticals …

[PDF][PDF] De novo Design of Natural Product Mimetics by reaction-based molecule assembly and generative deep learning

L Friedrich - 2019 - research-collection.ethz.ch
Natural products (NPs) provide an almost unlimited repository of inspirations for new drug-
like molecules.[1–3] Various strategies to harness the full potential of natural products have …

Open-access activity prediction tools for natural products. Case study: hERG blockers

F Mayr, C Vieider, V Temml, H Stuppner… - Progress in the Chemistry …, 2019 - Springer
Interference with the hERG potassium ion channel may cause cardiac arrhythmia and can
even lead to death. Over the last few decades, several drugs, already on the market, and …

Health Benefits and Pharmacological Molecular Properties of Isoflavandiol (Equol): In-silico and in-vitro Updates

P Singh, PP Kushwaha, S Kumar - Phytochemistry: An in-silico and in-vitro …, 2019 - Springer
Equol (EQ) is metabolized product of daidzein which is beneficial for health, related with
positive outcome in various diseases such as osteoporosis, cancers, menopausal …

Deep learning for drug design: modeling molecular shapes

M Skalic - 2019 - repositori.upf.edu
Designing novel drugs is a complex process which requires finding molecules in a vast
chemical space that bind to a specific biomolecular target and have favorable physio …

[PDF][PDF] Identifying Analogues Of 2-Deoxyglucose, Alpha-D-Glucose and Beta-D-Glucose-6-Phosphate as Potential Inhibitors of Human Hexokinase II for the …

S Tanbin, NO Salim, FAA Fuad - Pertanika Journal of Science and …, 2019 - researchgate.net
The human hexokinase isoform II (HKII) is one of the important enzymes for dengue virus
(DENV) replication and thus has been suggested as a potential therapeutic target for DENV …

[图书][B] Deep Neural Networks and Embedding Methods in Drugs Interactions Analysis

P Liu - 2019 - search.proquest.com
Deep Neural Networks and Embedding Methods in Drugs Interactions Analysis Page 1 Deep
Neural Networks and Embedding Methods in Drugs Interactions Analysis LIU, Pengfei A Thesis …